Financial Planning & Analysis Director

Immunovant, Inc. is a clinical-stage biopharmaceutical company dedicated to enabling normal lives for people with autoimmune diseases. As trailblazers in FcRn inhibitor technology, the Company is boldly developing innovative therapies for a range of debilitating autoimmune diseases with significant unmet patient needs.

The Role:

Reporting to the CFO, this position will have broad financial planning, management reporting, analysis, and business partnership responsibilities. The FP&A team works closely with the CFO and the Leadership Team to develop operating plans and multi-year strategic planning scenarios. This role will serve as the primary finance business partner for Research & Development, owning planning, forecasting, and reporting for the clinical development portfolio and partnering closely with the respective business leaders. The role is responsible for providing timely and accurate financial guidance and analytics to all levels of business partners to inform key decision-making in pursuit of the company’s financial and operational objectives.

As part of the broader financial team at Immunovant, this role will have opportunities for organic learning and development across multiple areas including clinical development and operations, CMC, Investor Relations, Accounting, SEC Reporting, and Commercial, as important stakeholders. We are a small but mighty team, ensuring that our critically important research and development teams are enabled to do their very best work in the interest of our potential patients.

Key Responsibilities: 

• In collaboration with business partners, this individual will own development and monitoring of annual budgets, quarterly forecasts, and month-end reporting of actual results for Research & Development
• Support CFO with comprehensive multi-year strategic, financial plan including summarizations to the Board of Directors and executive leadership
• Own trial-level clinical cost models and the key assumptions for all active and planned studies, translating changes in clinical plans and scenarios into budget, forecast, and long-range plan impacts
• Lead the R&D quarterly forecast cycle, including gathering and confirming assumptions with clinical and program leaders, preparing R&D inputs to forecast and Board materials, and supporting parent-company forecast submissions
• Partner with Accounting on R&D month-end close, including review of CRO and clinical trial accrual estimates, budget-to-actual variance analysis, and assessment of timing versus permanent variances
• Partner with Clinical Procurement and Clinical Operations to evaluate CRO and vendor proposals, contracts, and change orders, quantifying risks and opportunities against forecast and cash flow